Finland· FI-REL-REL64719
Aldurazyme
A laronidase product containing laronidase, registered in Finland by Orifarm Oy. The same ATC class is registered in 12 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Laronidase is registered in 12 of 19 countries.
Countries holding a registration under ATC A16AB05 (laronidase), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Laronidase · ATC A16AB05
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Laronidase
- Manufacturer
- Orifarm Oy
- Country
- Finland (FI)
- ATC code
- A16AB05
- ATC class
- Laronidase
- Defined daily dose
- 1 TSD, E
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- fi_myyntilupa5132745 mlEUR 850.98
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for laronidase.
Graded by severity as the source publishes them — 2 minor. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Laronidase · interactions on record
2 records
Same medicine, other countries
Laronidase in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALDURAZYMESanofi B.V., Amsterdam
- United StatesALDURAZYMEGenzyme Corporation
- SpainALDURAZYME, 100 U/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONSanofi B.V.
- FranceALDURAZYME 100 U/ml, solution à diluer pour perfusionSANOFI (PAYS-BAS)
- United KingdomAldurazyme 500units/5ml concentrate for solution for infusion vialsSanofi
- BelgiumAldurazyme 100 U/mlSanofi
- IcelandAldurazymeGenzyme Europe B.V.
- Japanラロニダーゼ（遺伝子組換え）サノフィ
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Aldurazyme
- Liechtenstein · Aldurazyme
- Norway · Aldurazyme
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c353892c-1fca-414d-a424-6e3f598406c5 GET /v1/drugs/c353892c-1fca-414d-a424-6e3f598406c5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1",
"form": "infuusiokonsentraatti, liuosta varten",
"route": "Laskimoon",
"ddd_unit": "TU",
"strength": "100 U/ml",
"atc_label": "laronidaasi",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/03/253/001",
"fimea_rel_id": "REL64719",
"authorised_at": "2025-10-17"
}See everything about laronidase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.